Bioactive Compounds
-
B1104 AZD-92911 CitationTarget: EGFRSummary: Mutated forms EGFR inhibitor -
B1892 AzathioprineSummary: purine synthesis and GTP-binding protein Rac1 activation inhibitor -
B2181 AS-604850Summary: PI3Kγ inhibitor,selective and ATP-competitve -
B1697 ChlorpropamideSummary: Oral antihyperglycemic agent -
B2271 Phenytoin1 CitationSummary: inactive voltage-gated sodium channel stabilizer -
B1343 Phenoxybenzamine HClSummary: Adrenergic receptor antagonist -
B1576 Olopatadine HClSummary: Histamine blocker -
C6692 1-HydroxypyreneSummary: A biomarker for monitoring environmental exposure to polycyclic aromatic hydrocarbons -
C6792 IsoquinolineSummary: A pyridine analog serving as a scaffold for various alkaloids with anticancer and anti-inflammatory activities -
A8183 Trichostatin A (TSA)30 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor

